LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $23,218,000 | +140.7% | 722,972 | +96.2% | 0.00% | +100.0% |
| Q3 2016 | $9,646,000 | +20.6% | 368,439 | +6.8% | 0.00% | 0.0% |
| Q2 2016 | $7,996,000 | +25.7% | 344,956 | +48.2% | 0.00% | +100.0% |
| Q1 2016 | $6,363,000 | -5.9% | 232,746 | -2.1% | 0.00% | -50.0% |
| Q4 2015 | $6,765,000 | +98.6% | 237,779 | +22.0% | 0.00% | +100.0% |
| Q3 2015 | $3,406,000 | -4.2% | 194,861 | -1.2% | 0.00% | 0.0% |
| Q2 2015 | $3,557,000 | +175.3% | 197,270 | +90.0% | 0.00% | – |
| Q1 2015 | $1,292,000 | +13.4% | 103,812 | +7.1% | 0.00% | – |
| Q4 2014 | $1,139,000 | +8.0% | 96,906 | +20.7% | 0.00% | – |
| Q3 2014 | $1,055,000 | – | 80,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |